Teladoc Health (TDOC) Cash from Financing Activities (2016 - 2025)
Teladoc Health (TDOC) has disclosed Cash from Financing Activities for 12 consecutive years, with $1.1 million as the latest value for Q4 2025.
- Quarterly Cash from Financing Activities fell 46.36% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$551.7 million through Dec 2025, down 6736.81% year-over-year, with the annual reading at -$551.7 million for FY2025, 6736.81% down from the prior year.
- Cash from Financing Activities hit $1.1 million in Q4 2025 for Teladoc Health, up from -$3.6 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $22.2 million in Q1 2021 to a low of -$549.9 million in Q2 2025.
- Historically, Cash from Financing Activities has averaged -$24.3 million across 5 years, with a median of $1.9 million in 2024.
- Biggest five-year swings in Cash from Financing Activities: skyrocketed 699.37% in 2023 and later tumbled 14552.9% in 2025.
- Year by year, Cash from Financing Activities stood at $6.6 million in 2021, then tumbled by 33.87% to $4.4 million in 2022, then crashed by 140.52% to -$1.8 million in 2023, then surged by 215.94% to $2.1 million in 2024, then plummeted by 46.36% to $1.1 million in 2025.
- Business Quant data shows Cash from Financing Activities for TDOC at $1.1 million in Q4 2025, -$3.6 million in Q3 2025, and -$549.9 million in Q2 2025.